Escient Pharmaceuticals

📍 San Diego, United States🗓 Founded 2018👥 50 employees💰 Last funded Sep 2020
Biotechnology Research🌐 escientpharma.com
Website LinkedIn
Escient is a clinical-stage pharmaceutical company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory diseases. Our pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for the treatment of various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Based in San Diego, California, Escient is led by an experienced team with specific expertise in GPCR drug discovery and development and funded by top-tier life science investors.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Escient Pharmaceuticals?
Escient Pharmaceuticals has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Escient Pharmaceuticals last raise funding?
The most recent investment in Escient Pharmaceuticals recorded on gritt.io was in September 2020.
When was Escient Pharmaceuticals founded?
Escient Pharmaceuticals was founded in 2018.
What industry is Escient Pharmaceuticals in?
Escient Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Escient Pharmaceuticals based?
Escient Pharmaceuticals is headquartered in San Diego, United States.